BioMarin: Q2 Earnings Snapshot
By AP News
Published - Jul 31, 2023, 04:33 PM ET
Last Updated - Jul 31, 2023, 04:33 PM EDT
SAN RAFAEL, Calif. (AP) — SAN RAFAEL, Calif. (AP) — BioMarin Pharmaceutical Inc. (BMRN) on Monday reported second-quarter profit of $56 million.
On a per-share basis, the San Rafael, California-based company said it had profit of 29 cents. Earnings, adjusted for one-time gains and costs, were 54 cents per share.
The results surpassed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of 47 cents per share.
The rare disease biopharmaceutical posted revenue of $595.3 million in the period, also surpassing Street forecasts. Nine analysts surveyed by Zacks expected $591.5 million.
